CASTLE BIOSCIENCES, INC. Deferred Income Tax Expense (Benefit)
CASTLE BIOSCIENCES, INC. (CSTL) reported Deferred Income Tax Expense (Benefit) of -$13.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$3.00K.
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$10.00K.
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$907.00K.
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $116.00K, a 97.79% decline year-over-year.
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2025 was -$6.23M, a 544.54% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2024 was $1.40M.
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2023 was -$223.00K.
- CASTLE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2022 was -$1.88M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$13.00K 10-Q · filed 2026-07-30 | -$920.00K derived: sum of 3 quarters · filed 2026-07-30 | -$804.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-06 | -$917.00K derived: sum of 2 quarters · filed 2026-05-06 | -$801.00K derived: sum of 3 quarters · filed 2026-05-06 | -$5.47M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$791.00K derived: sum of 2 quarters · filed 2026-02-26 | -$5.46M derived: sum of 3 quarters · filed 2026-07-30 | -$6.23M 10-K · filed 2026-02-26 |
| 2025-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$4.55M derived: sum of 2 quarters · filed 2026-07-30 | -$5.32M 10-Q · filed 2025-11-03 | -$7.63M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$5.44M 10-Q · filed 2026-07-30 | -$7.74M derived: sum of 3 quarters · filed 2026-07-30 | -$2.49M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$770.00K 10-Q · filed 2026-05-06 | -$3.08M derived: sum of 2 quarters · filed 2026-05-06 | $2.17M derived: sum of 3 quarters · filed 2026-05-06 | $631.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.94M derived: sum of 2 quarters · filed 2026-02-26 | $1.40M derived: sum of 3 quarters · filed 2026-02-26 | $1.40M 10-K · filed 2026-02-26 |
| 2024-09-30 | $5.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $3.71M derived: sum of 2 quarters · filed 2025-11-03 | $3.71M 10-Q · filed 2025-11-03 | $3.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$1.54M 10-Q · filed 2025-08-04 | -$1.78M derived: sum of 3 quarters · filed 2026-02-26 | -$1.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | -$236.00K derived: sum of 2 quarters · filed 2026-02-26 | -$236.00K derived: sum of 3 quarters · filed 2026-02-26 | -$236.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$236.00K derived: sum of 2 quarters · filed 2026-02-26 | -$236.00K derived: sum of 3 quarters · filed 2026-02-26 | -$223.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $13.00K 10-Q · filed 2024-11-04 | -$25.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $13.00K 10-Q · filed 2024-08-05 | -$25.00K derived: sum of 3 quarters · filed 2025-02-27 | -$25.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-02 | -$25.00K derived: sum of 2 quarters · filed 2025-02-27 | -$25.00K derived: sum of 3 quarters · filed 2025-02-27 | -$1.99M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$38.00K derived: sum of 2 quarters · filed 2025-02-27 | -$2.00M derived: sum of 3 quarters · filed 2025-02-27 | -$1.88M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.96M derived: sum of 2 quarters · filed 2023-11-02 | -$1.84M 10-Q · filed 2023-11-02 | -$10.57M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$1.84M 10-Q · filed 2023-08-02 | -$10.57M derived: sum of 3 quarters · filed 2023-08-02 | -$10.57M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-03 | -$8.61M derived: sum of 2 quarters · filed 2023-05-03 | -$8.61M derived: sum of 3 quarters · filed 2023-05-03 | -$8.61M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | -$8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$8.74M derived: sum of 2 quarters · filed 2023-02-28 | -$8.74M derived: sum of 3 quarters · filed 2023-02-28 | -$8.74M 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |